The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Artelo Biosciences
Stock and Other Ownership Interests - Artelo Biosciences
Honoraria - Apobiologix; Creare; HERON; Mylan; TerSera
Research Funding - Amgen; BeyondSpring Pharmaceuticals
A phase II trial with the combination of plinabulin (plin) pegfilgrastim (peg): Evaluation of the reversal of peg’s immune-suppressive potential by the addition of plin to peg.
 
Douglas W. Blayney
No Relationships to Disclose
 
Stephan Ogenstad
No Relationships to Disclose
 
Yuankai Shi
No Relationships to Disclose
 
Ji Feng Feng
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Lihua Du
Employment - Dalian Wanchun Bulin
Leadership - Dalian Wanchun Bulin
Stock and Other Ownership Interests - Dalian Wanchun Bulin
Honoraria - Dalian Wanchun Bulin
Travel, Accommodations, Expenses - Dalian Wanchun Bulin
 
Lan Huang
Employment - BeyondSpring Pharmaceuticals
Leadership - BeyondSpring Pharmaceuticals
Stock and Other Ownership Interests - BeyondSpring Pharmaceuticals
Patents, Royalties, Other Intellectual Property - BeyondSpring Pharmaceuticals
 
Ramon Mohanlal
Employment - BeyondSpring Pharmaceuticals
Leadership - BeyondSpring Pharmaceuticals
Stock and Other Ownership Interests - BeyondSpring Pharmaceuticals
Patents, Royalties, Other Intellectual Property - BeyondSpring Pharmaceuticals
Travel, Accommodations, Expenses - BeyondSpring Pharmaceuticals